Please Wait...

BioClinica expands strategic eClinical leadership team

Masters and Stortini take key roles steering continued eClinical growth

July 15, 2015

BioClinica®, Inc., a specialty clinical trials services and technology provider today announced that in response to tremendous growth it has made two strategic new hires, one in product development and another in business operations. Joining the eClinical leadership team are Andrew Masters, Senior Vice President of Global Product Development and Technology, and Angelo Stortini, Senior Vice President, Business Operations.

"We're experiencing significant growth in our eClinical business having posted record bookings last year and the first half of 2015 and we're continuing on this growth trajectory," said BioClinica eClinical President Mukhtar Ahmed. "Expanding our leadership team with knowledgeable and talented individuals like Andrew and Angelo will continue to elevate our position in the industry."

Andrew Masters
Andrew Masters, Senior Vice
President of Global Product
Development & Technology

Andrew Masters was most recently vice president of global strategic innovation at PPD where he led new business model development for mobile, data simulation and other technologies including Preclarus™ award-winning analytics. In his new role, Masters will lead product development and technology services for BioClinica's eClinical business. "Andrew will help us to evolve our existing product suite and transition to our next generation cloud and patient-centered analytics platform," Ahmed said. With more than 20 years of industry experience, Masters previously held technology and leadership roles with DHL Express, Avnet, MCI Worldcom, and Lenovo where he led the consolidation and retirement of 9,000 worldwide legacy applications and related business processes. Masters, who has an MBA from Duke University, began his technology career with the U.S. Navy in Naval research.

Angelo Stortini
Angelo Stortini, Senior Vice
President, Business Operations

Angelo Stortini brings 30 years of business operations and professional services organization leadership to his new role at BioClinica. "Angelo will help us to optimize our business operations and processes across all eClinical divisions and provide an operating business infrastructure to grow our product and service lines," Ahmed said. Most recently Stortini was senior vice president at roundCorner, a cloud CRM provider, and prior to this was senior practice director for Oracle's global safety practice within the life sciences and healthcare business. Stortini has also held senior management positions with Siebel Systems, IBM, and Digital Equipment Corporation. He has a Bachelor of Science degree from LaSalle University and a Juris Doctor from Delaware Law School.

"BioClinica continues to strengthen our eClinical leadership team and both Andrew and Angelo will play key leadership roles as we expand our product portfolio and professional services capabilities," Ahmed said.

Follow BioClinica on the Trial Blazers blog at, and on Twitter at

About Bioclinica

Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval.  The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development.  The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '…
bioclinica (3 days ago)
RT @BrianSMcGowan: Allison Proffitt Editor of Clinical Informatics News, Best Practice Awards @ from Clin_Info_News ... recognizing applied…
bioclinica (5 days ago)
@Clin_Info_News @IQVIA_global @CRFHealth All of us @Bioclinica are truly honored to receive this recognition. Congr…
bioclinica (5 days ago)
RT @Clin_Info_News: Congrats again to @IQVIA_global @CRFHealth @bioclinica on winning the @Clin_Info_News Best Practices awards at #SCOPE20…
bioclinica (5 days ago)
And the winner is! Transformational Medical Imaging in #ClinicalTrials: @bioclinica SMART. @Clin_Info_News Best Pra…
bioclinica (5 days ago)
Folks at #SCOPE2018 hearing from Eric Forsthoffer and Rebecca Lupo about Bioclinica's Site Network.…
bioclinica (5 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen